Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4.
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
To find mammalian analogues of exendin-4, a peptide from Helodermatidae venoms that interacts with newly discovered exendin receptors on dispersed acini from guinea pig pancreas, we examined the actions of recent additions to the vasoactive intestinal peptide/secretin/glucagon family of regulatory peptides. In every respect tested, the truncated form of glucagon-like peptide-1, GLP-1(7-36)NH2, mimicked the actions of exendin-4. Like exendin-4, GLP-1(7-36)NH2 caused an increase in acinar cAMP without stimulating amylase release. GLP-1(7-36)NH2-induced increases in cAMP were inhibited progressively by increasing concentrations of the specific exendin-receptor antagonist, exendin(9-39)NH2. In dispersed acini from guinea pig and rat pancreas, concentrations of GLP-1(7-36)NH2 that stimulated increases in cAMP caused potentiation of cholecystokinin-induced amylase release. Binding of 125I-[Y39]exendin-4 or 125I-GLP-1(7-36)NH2 to dispersed acini from guinea pig pancreas was inhibited by adding increasing concentrations of unlabeled exendin-4 or GLP-1(7-36)NH2. We conclude that the mammalian peptide GLP-1(7-36)NH2 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Exendin(9-39)NH2, a competitive antagonist of the actions of GLP-1(7-36)NH2 in pancreatic acini, may be a useful tool for examining the physiological actions of this peptide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Self-citationDrucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903
Hamster preproglucagon contains the sequence of glucagon and two related peptides
Bell, G. I., Santerre, R. F., & Mullenbach, G. T. (1983) · Nature · doi:10.1038/302716a0 · Cited by 649
Exon duplication and divergence in the human preproglucagon gene
Bell, G. I., Sanchez-Pescador, R., Laybourn, P. J., & Najarian, R. C. (1983) · Nature · doi:10.1038/304368a0 · Cited by 593
Glucagon gene sequence. Four of six exons encode separate functional domains of rat pre-proglucagon
Heinrich, G., Gros, P., & Habener, J. F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89859-3 · Cited by 207
Research works printed but not linked: 37
- Eng, 1990, J. Biol. Chem., 265, 20259, 10.1016/S0021-9258(17)30498-2 · DOI
- Raufman, 1991, J. Biol. Chem., 266, 2897, 10.1016/S0021-9258(18)49932-2 · DOI
- Lopez, 1983, Proc. Natl. Acad. Sci. U. S. A., 80, 5485, 10.1073/pnas.80.18.5485 · DOI · Paper page
- Patzelt, 1984, Proc. Natl. Acad. Sci. U. S. A., 81, 5007, 10.1073/pnas.81.16.5007 · DOI · Paper page
- Mojsov, 1990, J. Biol. Chem., 265, 8001, 10.1016/S0021-9258(19)39030-1 · DOI · Paper page
- Kreymann, 1988, FEBS Lett., 242, 167, 10.1016/0014-5793(88)81008-1 · DOI · Paper page
- Shimizu, 1987, Endocrinology, 121, 1076, 10.1210/endo-121-3-1076 · DOI · Paper page
- Orkov, 1986, Endocrinology, 119, 1467, 10.1210/endo-119-4-1467 · DOI · Paper page
- Hoist, 1987, FEBS Lett., 211, 169, 10.1016/0014-5793(87)81430-8 · DOI · Paper page
- Kreymann, 1987, Lancet, 2, 1300, 10.1016/S0140-6736(87)91194-9 · DOI · Paper page
- Göke, 1991, Eur. J. Clin. Invest., 21, 135, 10.1111/j.1365-2362.1991.tb01802.x · DOI
- Fehmann, 1990, Pancreas, 5, 361, 10.1097/00006676-199005000-00019 · DOI
- Miyata, 1989, Biochem. Biophys. Res. Commun., 164, 567, 10.1016/0006-291X(89)91757-9 · DOI · Paper page
- Ohtakin, 1990, Biochem. Biophys. Res. Commun., 171, 838, 10.1016/0006-291X(90)91222-E · DOI
- Le Meuth, 1991, Am. J. Physiol., 260, G265
- Cauvin, 1990, Peptides, 11, 773, 10.1016/0196-9781(90)90194-A · DOI
- Buscail, 1990, FEBS Lett., 262, 77, 10.1016/0014-5793(90)80158-F · DOI
- Gottschall, 1990, Endocrinology, 127, 272, 10.1210/endo-127-1-272 · DOI · Paper page
- Tatsuno, 1990, Biochem. Biophys. Res. Commun., 168, 1027, 10.1016/0006-291X(90)91132-C · doi:10.1016/0006-291x(90)91132-c
- Robberecht, 1991, Am. J. Physiol., 260, G97
- Raufman, 1991, Reg. Peptides, 36, 121, 10.1016/0167-0115(91)90200-Z · doi:10.1016/0167-0115(91)90200-z
- Peiken, 1978, Am. J. Physiol., 235, E743
- Ceska, 1969, Clin. Chim. Acta, 26, 437, 10.1016/0009-8981(69)90071-0 · doi:10.1016/0009-8981(69)90071-0
- Gardner, 1979, Biochim. Biophys. Acta, 583, 491, 10.1016/0304-4165(79)90066-7 · DOI
- Raufman, 1986, Regul. Pept., 14, 93, 10.1016/0167-0115(86)90208-9 · doi:10.1016/0167-0115(86)90208-9
- Christophe, 1976, J. Biol. Chem., 251, 4629, 10.1016/S0021-9258(17)33248-9 · DOI · Paper page
- Malhotra, 1991, Gastroenterology, 100, A653
- Gardner, 1982, Am. J. Physiol., 242, G547
- Collen, 1982, Am. J. Physiol., 242, G423
- Schmidt, 1985, Diabetologia, 28, 704, 10.1007/BF00291980 · DOI · Paper page
- Mojsov, 1987, J. Clin. Invest., 79, 616, 10.1172/JCI112855 · DOI · Paper page
- Komatsu, 1989, Diabetes, 38, 902, 10.2337/diab.38.7.902 · DOI · Paper page
- Orskov, 1988, Endocrinology, 123, 2009, 10.1210/endo-123-4-2009 · DOI · Paper page
- Hoosein, 1984, FEBS Lett., 178, 83, 10.1016/0014-5793(84)81245-4 · DOI
- Schjoldager, 1989, Dig. Dis. Sci., 34, 703, 10.1007/BF01540341 · DOI · Paper page
- Schmidtler, 1991, Am. J. Physiol., 260, G940
- Fehmann, 1991, Biochim. Biophys. Acta, 1091, 356, 10.1016/0167-4889(91)90200-H · DOI
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“Cloning of the human pancreatic GLP-1R cDNA was also used to demonstrate comparable binding affinity of exendin-4 and exendin (9e39) to human GLP-1R [363], and consolidated the work of Jean-Pierre Raufman and John Eng that identified exendin-4 as a GLP-1 paralog [366] and exendin (9e39) as a GLP-1R antagonist [367].”
ResultKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Göke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., & Göke, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36565-2 · Cited by 837
Self-citationMechanisms of action of glucagon-like peptide 1 in the pancreas
Doyle, M. E., & Egan, J. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.007 · Cited by 680
Incretin-based therapies for type 2 diabetes mellitus
Lovshin, J. A., & Drucker, D. J. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.48 · Cited by 649
Metadata
- Authors
- Raufman, J. P., Singh, L., Singh, G., & Eng, J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1992-10
- Volume
- 267
- Issue
- 30
- Pages
- 21432-21437
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1558182564
- Cited by
- 122
- References
- 5
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 10225 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. https://app.cochat.ai/papers/10.1016/s0021-9258(19)36628-1
- The paper
- Raufman, J. P., Singh, L., Singh, G., & Eng, J. (1992). Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)36628-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.